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Thiol groupTo ﬁnd out whether and how the adenine nucleotide translocator-1 (ANT-1) inhibition due to NH2htau and
Aβ1-42 is due to an interplay between these two Alzheimer's peptides, ROS and ANT-1 thiols, use was made of
mersalyl, a reversible alkylating agent of thiol groups that are oriented toward the external hydrophilic phase,
to selectively block and protect, in a reversible manner, the –SH groups of ANT-1. The rate of ATP appearance
outside mitochondria was measured as the increase in NADPH absorbance which occurs, following external
addition of ADP, when ATP is produced by oxidative phosphorylation and exported from mitochondria in the
presence of glucose, hexokinase and glucose-6-phosphate dehydrogenase. We found that the mitochondrial
superoxide anions, whose production is induced at the level of Complex I by externally added Aβ1-42 and
whose release from mitochondria is signiﬁcantly reduced by the addition of the VDAC inhibitor DIDS, modify
the thiol group/s present at the active site of mitochondrial ANT-1, impair ANT-1 in a mersalyl-preventedmanner
and abrogate the toxic effect of NH2htau on ANT-1 when Aβ1-42 is already present. A molecular mechanism is
proposed in which the pathological Aβ-NH2htau interplay on ANT-1 in Alzheimer's neurons involves the thiol
redox state of ANT-1 and the Aβ1-42-induced ROS increase. This result represents an important innovation be-
cause it suggests the possibility of using various strategies to protect cells at the mitochondrial level, by stabilizing
or restoring mitochondrial function or by interfering with the energy metabolism providing a promising tool for
treating or preventing AD.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The histopathological characteristics of Alzheimer's disease (AD) are
amyloid-β (Aβ) containing plaques and neuroﬁbrillary tangles (NFTs)
as well as neuronal and synaptic loss [1]. The underlying mechanisms
of the interplay of plaques and tangles have remained essentially
unresolved. Moreover, studies in several amyloid precursor protein and
tau transgenic mouse models suggest that a possible link between
these two characteristic AD hallmarks might be an early mitochondrial
dysfunction, particularly at synapses, associated with increased oxidative
stress [2–8]. The impairment of mitochondrial oxidative phosphorylationheimer disease; ANT-1, adenine
enta-phosphate; ATP D.S., ATP
tyrate; CGCs, cerebellar granule
cyanatostilbene-2,29-disulfonic
thyl-maleimide; NFTs, neuroﬁ-
hosphorylation; PBS, phosphate
respiratory chain; RCI, respirato-
ard deviation; –SH groups, thiol
VDAC, voltage-dependent anion
+39 080 5443317.
l rights reserved.(OXPHOS), proportional both to cholinergic defects [9] and to clinical dis-
ability [10], has been extensively documented in the brain of AD patients
[11]. Studies from molecular, cellular, animal models and postmortem
brains have consistently revealed a causative role of mitochondrial
dysfunction in AD synapse failure [12–15].
Recently, we have shown that a neurotoxic NH2-tau fragment of
the human tau40 isoform (441 amino acids), but not the physiologi-
cal full-length protein, preferentially interacts with Aβ peptide(s) in
human AD synapses in association with mitochondrial adenine nucle-
otide translocator-1 (ANT-1). Two Alzheimer's peptides – Aβ1-42 and
the smaller and more potent Tau peptide NH2-26-44 (NH2htau), the
minimal active moiety of longest overexpressed NH2-26-230 human
tau fragment(s) [16] – inhibit the ANT-1 in a non-competitive and
competitive manner, respectively, and together further aggravate
mitochondrial dysfunction by exacerbating ANT-1 impairment, thus
leading to dysfunction in energy metabolism prior to induction of
cell death [16–18].
In this paper we dissect the molecular mechanism by which NH2-
htau and Aβ1-42 impair mitochondrial ANT-1. Since it is known that
ANT contains –SH groups, which are both essential for the catalytic
activity and preferential targets for reactive oxygen species (ROS)
attack, we have investigated whether the ANT-1 inhibition is due to
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thiols. To accomplish this purpose we turned to mersalyl (MERS), a
reversible alkylating agent of thiol groups that are oriented toward
the external hydrophilic phase [19], to selectively block and protect
the –SH groups of ANT-1 in a reversible manner.
The ability of Aβ1-42 to induce mitochondrial ROS production and
of mersalyl to protect ANT-1 against truncated NH2htau, but not
Aβ1-42, were observed.
2. Materials and methods
2.1. Ethics statements
This study was performed in accordance with the local ethics com-
mittee and with the principles contained in the Helsinki Declaration,
as revised in 1996. All animals were handled and cared for in accor-
dance with EEC guidelines (Directive 86/609/CEE).
2.2. Reagents
Synthetic NH2htau peptides were synthesized by Sigma Genosys
(Haverhill, UK) and puriﬁed to >95% homogeneity by reversed-
phase high pressure liquid chromatography on C-18 silica columns
with monitoring of A214 (peptide bonds).
Aβ1-42 and the inverse sequence peptide, Aβ42-1, (Sigma
Chemicals Co., St. Louis, MO, USA) were prepared according to Eckert
et al. [5] with minor modiﬁcations. The peptides were dissolved in
deionized water at a concentration of 0.5 mM and stored at −20 °C.
At occurrence, the peptide stock solution was diluted in phosphate
buffer saline medium (PBS) to a concentration of 0.1 mM and
incubated at 37 °C, with gentle agitation, for 24 h to obtain aged,
aggregated preparations of peptide.
2.3. Cell culture and treatments
Primary cultures of cerebellar granule cells (CGCs) were obtained
from 7-day-old Wistar rats as described by Levi et al. [20]. Cells were
plated in basal medium Eagle (Invitrogen, Gibco) supplemented with
10% fetal calf serum, 25 mMKCl, 2 mM glutamine, and 100 μg/mL gen-
tamicin on dishes coated with poly-L-lysine. Arabinofuranosylcytosine
(10 μM) was added to the culture medium 18 to 22 h after plating to
prevent proliferation of non neuronal cells.
2.4. Cell homogenate preparation
Cultured medium was removed and the plated CGCs were washed
with PBS, containing 138 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and
15 mM KH2PO4, pH 7.4. Cell integrity was quantitatively assessed by
the inability of cells to oxidize externally added succinate, and by
the ability of ouabain to block glucose transport. Homogenates were
prepared from a cell suspension by 10 strokes with a Dounce homog-
enizer at room temperature. Cytosolic lactate dehydrogenase was
released and subsequent treatment with Triton-X-100 did not cause
further release. Consistently with Atlante et al. [21], homogenate,
containing mitochondria, was checked both for the mitochondrial
coupling efﬁciency by measuring both the respiratory control index
(RCI), i.e. (oxygen uptake rate after adenosine diphosphate [ADP]
addition) / (oxygen uptake rate before ADP addition), which reﬂects
the ability of mitochondria to produce adenosine triphosphate
(ATP), and the generation of membrane potential (Δψ), monitored
by the decrease of safranine O absorbance at 520 nm, and for the
intactness of the mitochondrial membranes, by measuring in the
postmitochondrial supernatant the activities of adenylate kinase
(ADK, E.C.2.7.4.3) and glutamate dehydrogenase (GDH, E.C.1.4.1.3),
which are marker enzymes of the mitochondrial intermembrane
space and matrix, respectively. Protein content was determinedaccording to Waddell and Hill [22] with bovine serum albumin used
as a standard.
2.5. Polarographic measurements
O2 consumption was measured polarographically by means of a
Gilson 5/6 oxygraph using a Clark electrode see [21]. The cell homoge-
nate in PBS (about 0.2 mg protein) was incubated in a thermostated
(25 °C) water-jacketed glass vessel (ﬁnal volume equal to 1.5 ml), and
polarographic measurements were performed in the presence of
1 mM ADP or 0.1 μM FCCP. The substrate used was β-hydroxybutyrate
(β-OH, 5 mM). Instrument sensitivity was such as to allow rates of O2
uptake as low as 0.5 natom min−1 mg−1 protein to be followed.
2.6. ANT-1-mediated ADP/ATP exchange measurements
Cell homogenates (0.1 mg protein), containing mitochondria,
were incubated at 25 °C in 2 ml of standard medium consisting of
200 mM sucrose, 10 mM KCl, 1 mM MgCl2, and 20 mM HEPES–Tris,
pH 7.2. The appearance of ATP in the extramitochondrial phase, due
to externally added ADP, was assayed, as in Atlante et al. [17,21], by
using the ATP detecting system (ATP D.S.) consisting of glucose
(2.5 mM), hexokinase (HK, 0.5 e.u.), glucose-6-phosphate dehydro-
genase (G-6-PDH, 0.5 e.u.), and NADP+ (0.2 mM) in the presence of
10 μM P1,P5-Di(adenosine-5′)pentaphosphate (Ap5A), a speciﬁc
inhibitor of adenylate kinase. The coupled enzymatic system used to
detect ATP outside mitochondria was proved not to be rate limiting
per se since while the addition of 5 μM ATP resulted in an increase
in the rate of absorbance, no rate increase occurred following the
addition of both substrate and enzyme components of the ATP
detecting system. Similarly it has always been veriﬁed that the
NADP+ reduction was a measure of the ADP/ATP exchange rate, via
ANT-1 (see Results).
Furthermore, control experiments were carried out in the presence
of either atractyloside (ATR) or oligomycin (OLIGO) to ensure that both
the ADP/ATP exchange was mediated by the ADP/ATP carrier and no
substrate-level phosphorylation occurs, respectively [17,21]. Worthy
of note is the uniqueness of this model, in which mitochondria are
both intact and coupled thus providing a ‘physiological’ environment
for the investigation of ANT-1 in situ.
The rate of NADP+ reduction, which is the measure of the ADP/ATP
exchange via ANT-1, in the extramitochondrial phase was determined
following the absorbance increase at 340 nm, measured as the tangent
to the initial part of the progress curve and expressed as nmoles
NADP+ reduced / minute × mg cell protein.
2.7. Superoxide anion detection
O2−• was detected according to the Fe3+-cyt c method [23,24] and
by using the MitoSox dye (for refs see [25,26]). In the Fe3+-cyt c
method, cell homogenate in PBS (about 0.2 mg of protein/2 ml) was
incubated at 25 °C in the presence of Fe3+-cyt c (10 μM) plus a mito-
chondrial respiratory substrate, such as succinate (5 mM), under ex-
perimental condition in which succinate-driven ROS generation is
largely due to the reverse electron transport (RET) (see [27–30] and
references therein).
The increase in absorbance at 550 nm, i.e. Fe2+-cyt c formation
(ε550 = 31.7 mM−1 cm−1), was measured using a PerkinElmer LS-5
spectrophotometer equipped with a thermostated holder. A calibration
curve is made by using an O2−•-producing system, i.e. xanthine
(XX) + xanthine oxidase (XOD).
To speciﬁcally detect superoxide anion production of mitochondrial
origin use was made of MitoSOX Red, a speciﬁc mitochondrial dye –
highly and exclusively sensitive to superoxide [25,26], but not to
other reactive oxygen/nitrogen species – which is selectively targeted
to mitochondria where it accumulates as a function of mitochondrial
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superoxide and subsequent binding to mitochondrial DNA. Cell ho-
mogenate in PBS was preincubated with succinate (10 mM) plus ADP
(2.5 mM) for 2 min at 25 °C. After addition of 1 μM MitoSOX red and
further 15 min incubation, ﬂuorescence emission at 580 nm was mea-
sured using a Perkin-Elmer LS-50B Luminescence Spectroﬂuorimeter.
Fluorescence spectra (λex = 396 nm; λem range: 500–700 nm)
were recorded under the same experimental conditions.
2.8. Statistical analysis
Experiments were carried out in triplicate and repeated at least 3
times. Data are expressed as means ± standard deviation (S.D.)
(n > 3). Difference between control and treated groups were analyzed
with SPSS software by 1-way analysis of variance (ANOVA) for
repeated measures followed by the post-hoc Bonferroni test for multi-
ple comparisons. Statistical differences were determined at p b 0.05.
Experimental plots were obtained using Graﬁt (Erithacus Software).
3. Results
The ADP/ATP carrier, that mediates the exchange transport of ADP
and ATP in mitochondria, is essential for the synthesis of ATP by
oxidative phosphorylation which supplies bioenergy for various
biochemical reactions. Furthermore we have recently demonstrated
that NH2htau and Aβ1-42 impair mitochondrial ANT-1 [17,18].
Taking into account that the ANT contains four –SH groups
involved in the transport activity [31,32], which are also known to
be the main targets of ROS [33,34] and with the aim to investigate
the mechanism of inhibition exerted by the AD peptides on the ANT
activity, essential studies were performed to ascertain: i) whether
ANT-1 activity was affected either by mersalyl or by ROS-producing
system; ii) whether there was any interaction between the carrier
thiol/s and ROS; and iii)whether and how the interaction of NH2htau
and Aβ1-42 with ANT-1 involves carrier thiol/s.
First, to illustrate at present the state of the art on this topic, a
comprehensive scheme on the effect of the AD peptides on ANT-1
together with kinetic characteristics, relevant references and the
novelty use of Aβ42-1 in this paper, is reported in Table 1.
3.1. Effects of either mersalyl or ROS-producing system on ANT-1 activity
To determine whether and how ANT-1-mediated ADP/ATP
exchange was affected by either mersalyl (Fig. 1) or ROS-producingTable 1
Effect of Alzheimer's peptides on ANT-1.
Peptide ANT-1
V p Inhibition Nature Ki Refs.
No peptide 10.0 + 0.8 - - - 21
Aβ1-42 7.0 + 0.5 < 0.05 Non Competitive 2 μM 18
Aβ42-1 9.5 + 0.6 > 0.05 No - this paper
NH226-44 tau 1.8 + 0.3 <0.01 Competitive 0.1 μM 17-18
NH21-25 tau 9.7 + 0.5 > 0.05 No - 17
All the peptides – Aβ 1-42, Aβ 42-1, NH2-26-44, i.e. NH2htau, and NH2-1-25 – were
added at a ﬁnal concentration of 1 μM. ANT-1 is measured following the appearance
of ATP, due to ADP (0.1 mM) addition to CGC homogenates (0.1 mg protein), and mon-
itored photometrically at 340 nm (for details see Materials and methods (2.6 section)
and refs. [17,18,21]).
V indicates the rate values – expressed as nmoles NADP+ reduced/min x mg protein –
means ± SD from ﬁve experiments carried out using different cell preparations. Statis-
tical analysis was by ANOVA and Bonferroni test: p b 0.05, p b 0.01 when all the
samples were compared with the control, i.e. no peptide. When p > 0.05: differences
are not statistically signiﬁcant.system, i.e. XX + XOD (Fig. 2), the rate of supply in the cytosol of
ATP, produced by OXPHOS, was continuously measured by using a ki-
netic approach already used and validated in our previous papers
[17,21]. Since this unique experimental model strictly requires that
mitochondria are intact and coupled to provide a ‘physiological’
environment for the investigation of ANT in situ, before starting
each experiments, cell homogenate was routinely checked for both
the functional integrity of mitochondria and the generation of
membrane potential (see Materials and methods, Sections 2.4 and
2.5 respectively).
In a typical experiment, the homogenate, treated with AP5A
(10 μM) to inhibit adenylate kinase (for ref see [21]) and to prevent
mitochondrial ATP synthesis in a manner not dependent on OXPHOS,
was incubated in the presence of an ATP detecting system (ATP D.S.)
(see Materials and methods, Section 2.6). The ATP concentration in
the extramitochondrial phase of the homogenates was negligible as
shown by the fact that no increase in the absorbance measured at
340 nm was found in the presence of glucose, hexokinase,
glucose-6-phosphate dehydrogenase and NADP+. As a result of ADP
addition (0.1 mM), an increase in the NADPH absorbance was ob-
served, indicating the appearance of ATP in the extramitochondrial
phase. The rate of NADPH formation was approximately 10 nmol
NADP+ reduced/min mg cell protein (Fig. 1A, trace a), in good agree-
ment with values obtained by Atlante et al. [17,21]. NADPH formation
derives from i) ADP uptake into mitochondria in exchange for endoge-
nous ATP, ii) ATP synthesis from imported ADP via ATP synthase and
iii) efﬂux of the newly synthesized ATP from the mitochondria in ex-
change for further ADP via ANT-1. It should be noted that under the ex-
perimental conditions used the oxidation of endogenous substrates is
sufﬁcient to supply energy for ATP synthesis.
As expected, NADPH formation was completely inhibited by the
presence of oligomycin (OLIGO, 10 μM), the classical inhibitor of ATP
synthase, further conﬁrming that no ATP could be synthesized via
substrate-level phosphorylation in the homogenates (Fig. 1B, traces a).
The addition of ATR (10 μM), an impermeable ANT inhibitor, also
strongly inhibited NADPH formation, as expected in light of the Ki
value (about 3 μM) see [21] and of the ADP and ATR concentrations
used. Because the ANT-1-mediated ADP/ATP exchange could depend
on a number of events, including electron ﬂow across the mitochondrial
membrane, electrochemical proton gradient generation, ATP synthase
and the adenine nucleotide content of the mitochondria, we investigat-
ed the rate-limiting step of the process leading to ATP efﬂux from the
mitochondria. Then, to gain some insight into the residual ability of
the mitochondria to drive ATP synthesis by generating Δψ and to ascer-
tain whether this could limit the rate of ATP production, we energized
cell homogenates with β-hydroxybutyrate, a respiratory substrate that
enters mitochondria via diffusion with an increase in Δψ (see Fig. 1B,
traces b). The rate of ATP production was not signiﬁcantly increased
but addition of a cocktail of the electron ﬂow inhibitors, i.e. rotenone,
antimycin and mixothiazole (RAM) plus cyanide (CN−), totally
prevented ATP production, thus conﬁrming both that available energy
is not limiting the process and that the process depends exclusively on
the oxidation of endogenous substrates. Furthermore, also inorganic
phosphate (Pi), which is known to enter the mitochondria using its
own carrier and to be necessary for ATP synthesis, when added to the
homogenate did not inﬂuence the ADP/ATP exchange rate, thus proving
that endogenous Pi is sufﬁcient and not limiting for the process (Fig. 1B,
traces b).
To deﬁnitely conﬁrm that the method here employed, i.e. mea-
surement of the rate of NADPH formation, exclusively measures the
rate of ADP/ATP exchange in mitochondria [17,21], we applied the
control ﬂux coefﬁcient (control strength) criterion [35,36] for the
plot data when either ATR or OLIGO was used as inhibitor at
0.1 mM ADP. As shown in Fig. 1C, the coincidence of the intercepts
on the y axis of the lines ﬁtting the points obtained in the presence
of ATR, but not OLIGO, which – as known – inhibits ATP synthase,
Fig. 1. Effects of mersalyl on ANT-1-dependent ADP/ATP exchange. A) Appearance of ATP, due to ADP (0.1 mM) addition to CGC homogenates (0.1 mg protein), was monitored
photometrically at 340 nm, as described in the Materials and methods (2.6 section). Where indicated, additions were as follows: mersalyl (MERS, 0.05 mM), cysteine (CYS,
1 mM). The reaction was started by the addition of ADP at the time indicated by the arrow. For details see the text. B) Atractyloside (ATR, 10 μM), oligomycin (OLIGO, 10 μM),
β-hydroxybutyrate (β-OH, 5 mM), inorganic phosphate (Pi, 1 mM), the cocktail of respiratory chain inhibitors (RAM), i.e. rotenone (3 μM), antimycin A (0.8 μM) and mixothiazole
(6 μM), plus cyanide (CN−, 1 mM), were added to the reaction mixtures 1 min before ADP (0.1 mM). C) Dixon plot of the inhibition by either ATR or OLIGO, at the indicated con-
centrations, of the ADP/ATP exchange rate measured in CGC homogenate. The ADP concentration was 0.1 mM. Reported values are the mean of three independent neuronal prep-
arations (with comparable results) each one in triplicate with the standard deviation. D) Experimental conditions as in the panel A. The plot of 1/v vs the reciprocal of external ADP
concentration (a) was investigated in the absence (●) or presence of 0.05 mM Mersalyl (○) and the same data were replotted as 1/v vs the mersalyl concentration in a Dixon plot
(b) using two different ADP concentrations: 0.1 mM (○) and 0.25 mM (●). Reported values are the mean of four independent neuronal preparations (with comparable results)
each one in triplicate with standard deviation.
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NADPH formation, is indeed a measure of the ADP/ATP exchange.
When mersalyl (MERS, 50 μM) was added 1 min before ADP addi-
tion, the rate was strongly decreased to 1.7 nmol NADP+ reduced/
min mg cell protein, thus conﬁrming the sensitivity of ANT-1 –SH
group/s to the thiol reagent (Fig. 1A, trace b). Addition of 1 mMCYS, which reverse the reaction of MERS with functional thiols [37],
almost completely restores the NADPH formation rate (about
9.2 nmol NADP+ reduced/min mg cell protein) (Fig. 1A, trace b). As
expected, the simultaneous addition of CYS and MERS had no effect
on ATP appearance in the extramitochondrial phase (9.8 nmol
NADP+ reduced/min mg cell protein) thus conﬁrming the ability of
Fig. 2. Effects of ROS-producing system on ANT-1-dependent ADP/ATP exchange. A–B) Appearance of ATP, due to ADP (0.1 mM) addition to CGC homogenates (0.1 mg protein),
was monitored photometrically at 340 nm, as reported in Fig. 1. Where indicated, additions were as follows: xanthine (XX, 10 μM) plus xanthine oxidase (XOD, 1 e.u./ml), super-
oxide dismutase (SOD, 5 e.u./ml), mersalyl (MERS, 0.05 mM), cysteine (CYS, 1 mM). The reaction was started by the addition of ADP at the time indicated by the arrow. For details
see the text. In the inset to panel A: Experimental condition as in the panel. The Dixon plot of 1/absorbance increase rate vs the [XX + XOD]-incubation time, i.e. increased level of
superoxide over time, was investigated by using 0.1 mM ADP. Reported values are the mean of three independent neuronal preparations (with comparable results) each one in
triplicate with the standard deviation.
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the MERS inhibition was studied by investigating the dependence
of the NADPH formation rate as a function of ADP concentration in
cell homogenate in the absence or presence of the thiol reagent
(Fig. 1Da). A purely non competitive inhibition was found with a
Km value (i.e. the ADP concentration which gives half-maximum
rate of exchange) equal to 40 μM, and a Ki value (i.e. the concentra-
tion of MERS which gives 50% inhibition) equal to 15 μM.
When the experimental data of Fig. 1Da were replotted as 1/v vs
the MERS concentration in a Dixon plot (Fig. 1Db), straight lines
were obtained. Statistical analysis shows that the intercepts to the
ordinate axis, obtained by treating the experimental points according
to linear regression, coincide perfectly with the corresponding exper-
imental controls, i.e. in the absence of mersalyl. This clearly shows not
only that the measured inhibition is related to the same parameter
measured in the control, i.e. the rate of ADP/ATP exchange, but has
also the additional value of ruling out a possible inhibitory effect by
mersalyl on ATP synthase or other proteins having CYS residues, in
agreement with [17,18,21]. Moreover, appropriate controls were
carried out to exclude that the observed inhibition was due to the
effect of mersalyl on the ATP detection system.
Next, in order to conﬁrm that ANT-1 is target of ROS, as already ob-
served in CGCs undergoing apoptosis in which ROS level increases [38],
we carried out another set of experiments in which ANT-1-mediated
ADP/ATP exchange was monitored in the presence of an artiﬁcial ROS
generation system, i.e. the XX plus XOD, according to [39] (Fig. 2A). A
decrease in the ANT-1 transport efﬁciency occurs (trace b, 4.5 nmol
NADP+ reduced/min mg cell protein), likely due to –SH groups oxida-
tion, which is completely prevented by superoxide dismutase (SOD)
(trace c, 9.7 nmol NADP+ reduced/min mg cell protein).
By applying again the control strength criterion we veriﬁed that
XX/XOD-dependent ROS production inhibits ANT-1, but not ATPase(see inset to Fig. 2A). Also in this case, in fact, the intercepts to the y
axis, obtained by treating the experimental points according to linear
regression, coincides perfectly with the corresponding experimental
controls, i.e. in the absence of XX/XOD system. In order to eliminate
any doubt, the lack of inhibition by XX + XOD on ATP synthase activ-
ity was also conﬁrmed by measuring both the FCCP-stimulated swell-
ing of mersalyl-treated mitochondria incubated with ATP (for ref see
[17]) and the oligomycin-sensitive ATP hydrolase activity of Complex
V according to [40] (data not shown).
Fig. 2B shows an experimental strategy developed to study the capa-
bility of MERS to protect ANT-1 thiols from ROS attack. By analyzing
traces a–f step by step, it is clear that, as already seen above (Fig. 1), a
strong inhibition of the rate of NADPH formation was observed in the
presence of MERS which is reversed by CYS (comparing awith b). How-
ever, the 55% inhibition observed in the presence of (XX + XOD) (com-
paring awith c) is not reversed by CYS. When (XX + XOD) system was
added after MERS addition, the rates measured both before and after
CYS addition were no different from the control, i.e. in the absence of
ROS producing system (comparing b and d). On the contrary, no com-
plete CYS reversal was observed when the (XX + XOD) system was
added beforeMERS (e): in this case the rate, obtained after CYS addition,
is quite similar to that of trace c. As a control, it was veriﬁed that no in-
hibition occurred if both MERS + CYS and (XX + XOD) + SOD were
added before starting the reaction with ADP (f). The protection by
mersalyl against ROS attack strongly suggested that the ANT-1 impair-
ment derives from the action exerted by ROS on targets which are
apparently sensitive to mersalyl, i.e. –SH group(s) (for refs see [32]).
No effect by mersalyl on XOD + XX-dependent superoxide formation
was observed under the same experimental conditions used in the
ﬁgure (not shown).
In the light of the crucial role played by the ADP/ATP carrier in
OXPHOS, the effect of mersalyl or a ROS-producing system on oxygen
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to conﬁrm that the inhibition of ANT-1 likely involves its own thiol
group(s). The effect of mersalyl or ROS was investigated on State 3/
Uncoupled respiration in which oxygen uptake is stimulated either by
addition of ADP or by using an uncoupler, such as FCCP, respectively
(Fig. 3A). The difference is that in the former case the stimulation of ox-
ygen uptake derives from ADP used to drive ATP synthesis, whereas in
the latter case it derives from FCCP-dependent collapse of the electro-
chemical proton gradient without ATP synthesis. Mitochondria from
cell homogenate in State 4, i.e. in the presence of β-hydroxy-butyrrate
(βOH) alone, a respiratory substrate which enters mitochondria via dif-
fusion – thus ruling out the possibility that a membrane translocator of
an energetic substrate, for example the dicarboxylate carrier which
transport succinate into mitochondria, can limit the overall process
of oxygen consumption – took up oxygen at a rate of 12 natom
O2/min mg cell protein. When ADP was added, the rate increased upFig. 3. Effects of either mersalyl or a ROS-producing system on ADP/FCCP-stimulated m
β-hydroxybutyrate. A) CGC homogenate (0.1 mg cell protein) was suspended in standard m
polarographically. β-hydroxybutyrate (β-OH, 5 mM), ADP (1 mM), FCCP 0.1 μMwere added
10 μM) plus xanthine oxidase (XOD, 1 e.u./ml), superoxide dismutase (SOD, 5 e.u./ml), wh
respiration, i.e. in the absence of ADP. Rates of oxygen uptake were expressed as natom O2/m
were expressed as % of control sample, i.e. no addition. A value of 100% is given to the ox
uncoupled respirationFCCP. Reported values are the mean of three independent neuronal pre
Statistical analysis was by ANOVA and the Bonferroni test. For the state 3ADP: *p b 0.01 whe
with sample in absence of any addition.to 63 natom O2/min mg cell protein with an RCI value equal to 5.2
(trace a). In the presence of either MERS (trace b) or the (XX + XOD)
system (trace c), added 1 min before βOH, the rate enhancement due
to ADP phosphorylation was strongly reduced. But, when CYS or SOD
was added simultaneously with either MERS or the ROS-producing sys-
tem, the ADP rate increase was recovered (traces d and e, respectively).
On the other hand, the addition of FCCP increased the rate of oxygen
uptake up to 98 natom O2/min mg cell protein (trace a′) with an
Uncoupling Control Ratio (UCR, the ratio of the rate of oxygen uptake
in uncoupled respiration and State 4) equal to 8. No change in the
rate of oxygen uptake occurred when either MERS or (XX + XOD)
was added separately either before (traces b′ and c′, respectively) or
after the respiratory substrate (not shown), further conﬁrming that
the electron ﬂow along the respiratory chain is not affected by either
of the compounds. Statistical analysis of the experimental data, carried
out in triplicate and repeated 3 times, reported in Fig. 3B, conﬁrms thatitochondrial respiration (state 3/uncoupled respiration) by CGC homogenate due to
edium at 25 °C in a water-jacketed glass vessel and consumption of O2 was monitored
at the indicated times. Mersalyl (MERS, 0.1 mM), cysteine (CYS, 1 mM), xanthine (XX,
en present, were added 1 min before β-OH addition. They had no effect on state 4 of
in mg cell protein. B) Sample prepared as described in A). The rates of oxygen uptake
ygen consumption rate value after ADP addition for state 3ADP or after FCCP addition
parations (with comparable results) each one in triplicate with the standard deviation.
n oxygen consumption in the presence of either MERS or (XX + XOD) was compared
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XX + XOD after ADP addition is statistically signiﬁcant (*p b 0.01
with respect to control).
3.2. Aβ triggers mitochondrial increase of ROS production
Mitochondrial dysfunction has been identiﬁed in sporadic and
familial AD cases [41,42] as well as in AD mouse model [43] in part
due to elevated Aβ-induced oxidative stress. Since the mitochondrial
respiratory chain (RC) is the major source of ROS in most cells [44], in
a ﬁrst set of experiment we veriﬁed whether Aβ1-42 is able to induce
mitochondrial production of ROS when added to the CGC homoge-
nate (Fig. 4). In order to do this, two methodological approaches
were adopted: the Fe3+-cyt c method, already used in our previous
studies [23,38,45], and another method, sensitive only to superoxide
of mitochondrial origin, which utilizes MitoSOX, a ﬂuorogenic dye
that selectively targets mitochondria.
In a typical experiment, when cell homogenate in PBS was incu-
bated in the presence of Fe3+-cyt c and the mitochondrial respiratory
substrate succinate (SUCC, 5 mM), no absorbance increase at 550 nm
due to reduction of Fe3+-cyt c was observed, i.e. negligible ROS
production was revealed (Fig. 4A, traces a). On the other hand, aFig. 4. Aβ-dependent ROS production by CGC homogenate. A) ROS production was started b
5 mM succinate in the absence (traces a) or presence of Aβ1-42 at 3 different concentration
The rate of Fe2+-cyt c production, i.e. superoxide anion formation, was measured as the ab
B) Experimental condition as in A). Aβ1-42 (5 μM) was added to PBS, either in the absen
inset, as a control, superoxide production in homogenate oxidizing succinate was induce
(0.2 mg protein/ml), preincubated with 10 mM succinate, 2.5 mM ADP (or as indicated) fo
at 580 nm was recorded 15 min after Aβ (0.5–5 μM) or 5 μM Aβ42-1 or 0.15 μM Antimycin
In the insets 1–2, ﬂuorescence spectra (λex = 396 nm; λem range: 500–700 nm) were re
arbitrary units (a.u.). The experiment was repeated four times giving values with 5–10% v
(5 μM) + SOD (trace e). Inset 2: No addition (trace a′), AA (trace b′), AA + SOD (trace c′),progressive increase in superoxide anion production was found in
the presence of Aβ1-42 at concentrations ranging from 0.5 to 5 μM
(Fig. 4A, traces b) which is completely prevented by the antioxidant
SOD (Fig. 4A, traces c). Moreover, the absorbance signal in the
Aβ1-42-treated homogenate was completely suppressed in the
presence of the uncoupler FCCP (Fig. 4B, traces a) and the voltage-
dependent anion channel blocker DIDS (Fig. 4B, traces b) indicating
that [Aβ]-dependent superoxide production is predominantly medi-
ated by mitochondria and that Aβ directly participates in the onset
of oxidative stress in AD. As a control, no absorbance increase at
550 nm (i.e. no superoxide formation) was measured in the absence
or presence of either Aβ or cell homogenate (data not shown).
That the succinate-driven ROS generation is largely due to RET,
consistently with [27–30,46], is proved by the almost complete inhi-
bition of the superoxide production rate by the Complex I blocker ro-
tenone (Fig. 4B, traces c). Taking into account that notwithstanding in
vivo the major reducing equivalent that supports the respiratory
chain is NADH, and that both forward and reverse electron ﬂuxes
along the respiratory chain are linked to superoxide formation
in vitro, the residual activity observed with SUCC in the presence of
rotenone can be likely attributed to the combined superoxide gener-
ation by Complex II and Complex III (see [47]). Consistently, wey the addition of homogenate (0.2 mg protein/ml) to PBS added with 10 μM Fe3+-cyt c,
s (traces b): 0.5, 2 and 5 μM. Superoxide dismutase (SOD, 5 e.u./ml) addition (traces c).
sorbance increase at 550 nm and expressed as nmol of O2• formed/min x mg protein.
ce or presence of FCCP (0.1 μM) (a), DIDS (1 mM) (b) or rotenone (3 μM) (c). In the
d, under artiﬁcial condition, by antimycin A (0.15 μM) addition. C) Cell homogenate
r 2 min, was added with 1 μM MitoSOX with stirring at 25 °C. Fluorescence emission
A (AA) addition. Where indicated SOD (5 U/ml) or Rotenone (ROT, 3 μM) were present.
corded under the same experimental conditions. Fluorescence intensity is reported in
ariation. Inset 1: No addition (trace a), Aβ1-42 (0.5–2–5 μM) (traces b–c–d), Aβ1-42
5 μM Aβ42-1 (trace d′).
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in the presence of SUCC, under artiﬁcial conditions in which this
Complex is inhibited by antimycin A [48].
That the superoxide production observed in the presence of
Aβ1-42 is indeed of mitochondrial origin was further conﬁrmed by
MitoSOX analysis. Cell homogenate (0.2 mg protein/ml) which
contains respiring mitochondria in State 3 (i.e. in the presence of
10 mM succinate plus 2.5 mM ADP) was incubated with 1 μM
MitoSox with stirring at 25 °C. Mitochondrial O2−• production, mea-
sured as ﬂuorescence intensity, increased progressively depending
on Aβ1-42 concentrations (Fig. 4C) and was almost completely
prevented by SOD and ROT in accordance with results of Fig. 4A and
B. No MitoSox oxidation occurred when homogenate was incubated
with the reverse sequence peptide Aβ42-1, nor when Aβ 1-42 was
added to homogenate incubated with MitoSOX in the absence of
SUCC + ADP. As a control, it was veriﬁed that ﬂuorescence level
increased in the presence of antimycin A (0.15 μM), added after
1 min to stimulate O2−• generation by Complex III, and this effect
was reversed by SOD addition. As expected no O2−• formation, i.e. no
ﬂuorescence increase, was detected when MitoSox was added to
i) homogenate in the absence of SUCC + ADP, ii) medium with
SUCC + ADP but without homogenate, and iii) medium without
both homogenate and SUCC + ADP.
In parallel experiment, emission ﬂuorescence spectra, which
exibit a peak close to 580 nm due to the O2−• dependent MitoSOX ox-
idation, were carried out, essentially as in [49,50]. As shown in the
inset 1 to Fig. 4C, incubation of cell homogenate with Aβ1-42 usedFig. 5. SOD prevents the Aβ1-42-induced lowering level of inhibition by NH2htau on ANT-1. Exp
i.e., 2 μM, was incubated with homogenate 2 min before NH2htau (1 μM). The reaction was star
experimental conditions with the exception of the presence of superoxide dismutase (SOD, 5 e
protein. The % rate value is reported in brackets. The value (100) is given to ADP reaction, a); 100
of ADP/ATP exchange rate, expressed as % C, in the absence (●) or presence of either Aβ1-42 (○)
B were plotted as 1/i vs 1/[Inhibitor], with the fractional inhibition i = 1 − vi/vo (where vi an
Values are mean ± SD from ﬁve experiments, carried out using different cell preparations. Stati
were found for the dependence of ADP/ATP exchange rate in the absence of Aβ1-42 (●) versus A
the absence of Aβ1-42 (●) versus Aβ1-42 (○).at three different concentrations, induces a progressive increase of
the ﬂuorescence emission spectra (traces b–c–d) which is prevented
by SOD (trace e). No ﬂuorescence increase can be detected in the ab-
sence of Aβ (trace a). As a control, the same experiment carried out in
the presence of antimycin A (inset 2 to Fig. 4C) showed an increase of
the ﬂuorescence emission peak at 580 nm (trace b′) – with respect to
control (trace a′) – completely prevented by SOD (trace c′). As
expected, Aβ 42-1 doesn't induce any increase in ﬂuorescence (trace
d′). Worthy of note is that, besides Aβ42-1, also NH2htau does not
produce superoxide anion under the same experimental condition
(not shown), in agreement with [17].
3.3. ROS-mediated interaction between Aβ1-42, NH2htau and ANT-1
In our previous reports [17,18] we have demonstrated that i) the
two AD peptides, Aβ 1-42 and NH2htau individually impaired the
ANT-1 activity; ii) they further aggravate the mitochondrial dysfunc-
tion when added together, by exacerbating the ANT-1 impairment
and emphasizing a synergistic effect in perishing mitochondria; and
iii) Aβ1-42, added ﬁrst to cell homogenate, was able to decrease the
inhibitory effect of NH2htau on ANT-1 activity.
Thus, in the light of the ﬁnding that Aβ1-42 but not NH2htau or
Aβ42-1, induces an increase of mitochondrial ROS (Fig. 4), we inves-
tigated whether SOD, added together with Aβ and before the addition
of NH2htau, is able to modulate/prevent the inhibitory effect of NH2-
htau on ANT-1. To do this, pre-treatment of cell homogenate with
either Aβ1-42, at a concentration equal to its Ki value, i.e. 2 μM, orerimental conditions as in Fig. 1. In A (a–d): Aβ1-42, at concentration equal to its Ki value,
ted with ADP (0.1 mM) addition at the time indicated by the arrow. In A (a′–d′): the same
.u./ml) in the medium. The rate is expressed as nmol NADP+ reduced/minute per mg cell
* is the value given to the ADP reaction in the presence of Aβ1-42, b). In B: the dependence
or Aβ1-42 plus SOD (▲), on the concentration of NH2htau is reported. In C: data obtained in
d vo are the rates of ATP efﬂux in the presence or absence of the inhibitor, respectively).
stical analysis was by ANOVA and the Bonferroni test: no statistically signiﬁcant differences
β1-42 plus SOD (▲). *p b 0.01, **p b 0.001 for the dependence of ADP/ATP exchange rate in
Table 2
Protection by Mersalyl of ANT-1 thiol group/s from Aβ 1-42-produced ROS attack.
A-βeta + NH2hTau
line T = 0 T = 1' T =  4' CYS ADP V(%C)
1 − − Centrif + CYS ADP 100
2 Mersalyl − Centrif + CYS ADP 98
3 − NH2hTau Centrif + CYS ADP 18**
4 Mersalyl NH2hTau Centrif + CYS ADP 97
5 − A-βeta Centrif + CYS ADP 74*
6 Mersalyl A-βeta Centrif + CYS ADP 75§
7 − A-βeta + NH2hTau Centrif + CYS ADP 12**
8 Mersalyl Centrif + CYS ADP 73§
Rat cerebellar granule cell (CGC) homogenates (0.1 mg protein), containing
mitochondria, were incubated at 25 °C. Either NH
2
htau or Aβ1-42, at concentration
equal to 1 and 2 μM respectively, was incubated with homogenate 1 min after MERS
(50 μM) addition. At the time indicated in the table, the suspension was centrifuged
and the pellet, resuspended in 2.0 ml of standard medium (see Materials and
methods), was incubated with CYS (1 mM) and then with the ATP detection system.
Appearance of ATP due to ADP (0.1 mM) addition was monitored as described in the
Materials and methods. The value (100) is given to ADP reaction.
Values are mean ± SD from four experiments, carried out using different cell
preparations.
Statistical analysis was by ANOVA and Bonferroni test: *p b 0.01, **p b 0.001 when
compared all the samples (shaded lines) with each other; §p b 0.01 when compared
all the samples (clear lines) with each other.
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duces a decrease in the rate of ATP appearance up to 6.9 and 1.5 nmol
NADP+ reduced/min mg cell protein, respectively, as compared to
control (9.5 nmol NADP+ reduced/min mg cell protein) (Fig. 5A,
comparing a with b and c). No difference in the extent of inhibition
of the rate of ATP appearance was observed in the presence of SOD
(Fig. 5A, a′–c′). When Aβ1-42 was incubated with the cell homoge-
nate for 2 min before NH2htau (Fig. 5A, d), the rate of ATP appearance
was partially recovered (3.7 nmol NADP+ reduced/min mg cell
protein) and the inhibition extent decreased up to 47% while it was
85% in the case of the NH2htau added alone (comparing traces a
and b with traces c and d), in good agreement with [18]. Surprisingly,
the NH2htau inhibitory effect on the ANT-1 was almost completely
unaffected by Aβ1-42 (75 % inhibition vs 80%) if SOD was present
(comparing trace d with d′).
In Fig. 5B the dependence of the rate (V, %C) of ATP appearance on
the NH2htau concentrations was investigated in the absence (●) and
presence of Aβ1-42 (2 μM) either with (▲) or without SOD (○). As
shown, the level of inhibition by NH2htau, at various concentrations,
lowered in the presence of Aβ1-42, was recovered if SOD was added
together with Aβ, suggesting a mechanism of inhibition by NH2htau
which involves Aβ-mediated ROS production. To better investigate
this aspect, we developed an experimental strategy that allowed us
to solve the puzzle. Brieﬂy, we investigated the effect of mersalyl,
which – as shown above – is able to protect ANT-1 thiol/s from ROS
attack (see Fig. 2), added before exposure of ANT-1 to the peptides,
either added individually or together (Table 2). The mixture
ANT-1-MERS plus peptide (i.e. NH2htau or Aβ1-42 or NH2htau plus
Aβ1-42) was centrifuged in order to remove the supernatant
containing the unbound peptide/s and the resulting pellet was used
to follow the appearance of ATP due to ADP added after addition of
CYS which detaches the MERS bound to SH group/s. As shown in
Table 2, either NH2htau (line 3) or Aβ1-42 (line 5) or both of them
(line 7) were incubated with mitochondria for 3 min, after which
i) centrifugation was performed, ii) the pellet was resuspended,
iii) CYS was added and iv) NADPH formation was monitored after
ADP addition. As expected, the reaction rate, expressed as % of the
control to which value 100 (line 1) was given, was equal to 18, 74
and 12 for NH2htau, Aβ1-42 and NH2htau plus Aβ1-42 respectively
and consistently with [18]. When MERS was added 1 min before the
peptide, no NH2htau inhibition was detected (comparing lines 2 and
4) (97 vs 98). On the contrary, about 25% inhibition was conﬁrmed
when either Aβ1-42 or NH2htau + Aβ1-42 was/were added after
MERS (lines 6 and 8, respectively). These ﬁndings suggest that the
lack of the inhibitory effect of NH2htau on ANT-1, which occurred
when it was preceded by MERS, is likely due to a MERS-mediated
protection of –SH group/s involved in the interaction of NH2htau,
but not of Aβ1-42 with ANT-1. The same applied to the effect of
Aβ1-42 + NH2htau (line 8), thus further conﬁrming that the rate
of NADPH synthesis was strictly dependent on the treatment of
mitochondrial membrane with MERS, regardless of the interaction
between Aβ and NH2htau.
Now, in the light of our previous (see [18]) and new results in this
paper, we considered that Aβ1-42 induces a decrease of the inhibito-
ry effect by NH2htau on ANT-1. To further conﬁrm this point, data
obtained in Fig. 5B were plotted as 1/i vs 1/[Inhibitor] (Fig. 5C), with
the fractional inhibition i = 1 − vi/vo (where vi and vo are the rates
of ATP efﬂux in the presence or absence of the inhibitor, respectively).
We observed that the intercepts on the y-axis of the line obtained by
ﬁtting the experimental points obtained in the presence of NH2htau
fragment alone was 1, showing that NH2htau completely prevented
ADP/ATP exchange. On the contrary, when Aβ1-42 was present,
i.e. under conditions of decreased inhibitory effect by NH2htau on
ANT-1, the value on the y-axis intercept was not 1, this likely
suggesting a protective effect of Aβ1-42 against NH2htau toxicity
within the cell.4. Discussion
We discuss here the close inter-relationship between the impair-
ment of mitochondrial ANT-1 and the two main pathological features,
i.e. plaques and NFTs, or Aβ and truncated tau peptides, which occur
in the pathogenic process underlying AD [51]. Recently, we have
proved that a neurotoxic NH2-derived tau fragment mapping be-
tween 26 and 230 aa of the human tau40 isoform preferentially inter-
acts with Aβ peptide(s) in human AD tissues in association with
mitochondrial ANT-1 and Cyclophilin D. These two peptides, Aβ1-42
and NH2htau fragment, but not NH21-25 [17] nor Aβ 42-1 (Table 1),
inhibit ANT-1-dependent ADP/ATP exchange in a non-competitive
and competitive manner, suggesting that mitochondrial dysfunction
is triggered by ANT-1 impairment [18].
On the basis of these results to further investigate the process
which modulates the interaction of the NH2htau and Aβ1-42 peptides
with ANT-1, we turned to an experimental model consisting of rat
cerebellar granule homogenates (see Materials and methods, 2.4 sec-
tion) added with AD peptides, in agreement with (see [18]), as the
most appropriate and suitable experimental system to obtain infor-
mation on both the target protein of Aβ1-42 and NH2htau, i.e. mito-
chondrial ANT-1, and the interplay between the carrier protein and
the AD peptides. As far as the concentration of synthetic AD peptides
is concerned, the experimental 0.5–2 μM range, lower than the phys-
iological neuronal concentration, was used as in (see [18]), thus mim-
icking an in vivo situation. The choice of CGCs as experimental model
relies on the ﬁndings that during the onset of apoptosis of CGNs,
several molecular events reminiscent of AD are induced such as acti-
vation of the amyloidogenic process, cleavage of tau and production
of toxic fragments [see [52] and refs therein]. Furthermore emerging
literature claims about a cerebellar involvement in AD and arguing
deﬁnitively against the common practice of employing cerebellum
as a negative control in biochemical studies [see [53] and refs
therein].
We discuss ﬁrst the involvement of the –SH group/s of ANT-1 in its
activity to drive the export of ATP from the mitochondria in addition
to the role as ROS target; second, the Aβ-induced mitochondrial
extra-ROS production is brieﬂy considered; ﬁnally attention is fo-
cused on the molecular mechanism through which thiol group/s
modulate mitochondrial ANT-1 impairment in the presence of trun-
cated NH2tau and Aβ under increased ROS production conditions.
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mersalyl
In most mammalian cells, the major site of ATP synthesis is in the
mitochondria, through OXPHOS, while the major use of ATP is in the
cytosol and other intracellular organelles. Thus it is essential to have a
rapid mechanism for transporting ATP out of the mitochondria and
ADP back in. This is the major physiological role of ANT [54]. It is
constituted of 297 amino acid residues and among them the four
cysteines, i.e., CYS56, CYS128, CYS159, and CYS256 [55] are well
known target sites for thiol reagents such as eosin-5-maleimide,
mersalyl, and N-ethylmaleimide [56,57]. Mersalyl can react with the
–SH group in a reversible manner and this feature renders it suitable
for performing studies on the involvement of –SH groups in the tox-
icity exerted by the two Alzheimer's proteins toward mitochondria.
Notwithstanding mersalyl is an impermeable SH-reagent due to its
charged nature, as a matter of clarity it should be considered that
since both the ANT hydrophilic loop, containing CYS159, has been
proposed to intrude the translocation channel into the membrane
region, being accessible from the c-side [58,59], and the measurement
of ANT activity performed in our manuscript reﬂects a dynamic
situation in which the carrier molecule undergoes c- and m-state
transition, somehow, during the re-orientation of the carrier within
the membrane, this CYS residue could become transiently accessible
to mersalyl added from the cytosolic side.
Indeed, the experimental observations reported in this paper
show that the ANT-1 is strongly inhibited by mersalyl (Fig. 1), in
agreement with [60–62]. Non-competitive inhibition was observed
(Fig. 1) and, as expected, CYS was able to reverse/prevent the reaction
of mersalyl with functional thiols [37] thus restoring the activity of
the ANT-1. It should be noted that the use of other thiol reagents,
such as N-ethyl-maleimide (NEM), was excluded because NEM
gives an irreversible inhibition (not shown) (for refs see [55]).
This paper not only conﬁrms that ROS, also those produced by an
artiﬁcial system consisting of XX plus XOD, impair the ANT-1 in a
mersalyl-prevented manner, but it has the added dimension of show-
ing that thiol(s) in ANT-1 molecules is/are targets of ROS (Fig. 2A, B)
[for refs. see [37,63,64], thus suggesting that a chemical modiﬁcation
in the carrier molecule is responsible for the change in ANT-1 activity.
Our ﬁnding is consistent with the paper by Moreno et al. [65]: singlet
oxygen, produced by irradiation of photosensitizer-loaded mitochon-
dria, triggers permeability transition pore (PTP) opening and thiol
reagents, in particular mersalyl, prevent the PTP opening when mito-
chondria are irradiated after addition of mersalyl. This is in agreement
with the observation of Atlante et al. [66], according to which ANT is a
major target of ROS-dependent photodynamic action.
4.2. Aβ 1-42 increases ROS production by the mitochondrial respiratory
chain
It is now widely accepted that oxidative stress, manifested by
protein oxidation, lipid peroxidation and mtDNA damage is a charac-
teristic of AD brain [4,6,13] and Aβ1-42 has proved to induce oxida-
tive stress in AD brain in a manner prevented by vitamin E [67],
catalase or synthetic catalytic free radical scavenger [68,69]. Among
the sources of ROS within a cell, mitochondria are the main producer
of superoxide anion [44,64] and with the recent theory of RIRR (ROS
Induced-ROS Release from mitochondria) [70] they have also a key
role in determining ROS dynamics within a cell [71,72].
By using a method which measured the RET due to succinate addi-
tion and which is rotenone-sensitive [27–30], we demonstrated that
external addition of Aβ1-42 to cell homogenate was able to induce
ROS production likely at the level of Complex I. It should be noted
that SUCC was used as an energy substrate under both the experi-
mental conditions used, i.e. Fe3+-cyt c and MitoSox, to emphasize
more strongly that an increase of mitochondrial ROS productionoccurs in the presence of Aβ see experiment of Fig. 4). Aβ dependent
ROS extra-production still occurs in the presence of the sole endoge-
nous mitochondrial substrates as shown in the experiments of Fig. 5
and Table 2 where energy substrate was not externally added.
On the other hand, Aβ1-42 did not induce production of ROS at
Complex III, under the experimental conditions in Fig. 4. Consistent
with this ﬁnding is the general opinion that the Complex I seems to
be a more relevant location for Aβ-induced ROS formation, although
the precise mechanism and the physiological and pathological condi-
tions that promote the one-electron reduction of oxygen at this site
require further clariﬁcation [73]. Nevertheless we cannot exclude at
this time that other source of ROS may be involved. Anyway, further
investigations are underway both to resolve this question and to
investigate the effect of Aβ1-42 on mitochondrial respiration in a
general context (manuscript in preparation).4.3. Role of thiol redox state in modulating mitochondrial ANT-1 activity
in the presence of NH2htau and Aβ1-42
This study was undertaken with the aim of providing additional data
on the possible participation of ANT-sulfhydryl groups in regulating
ANT-1 activity in the presence of both NH2htau and Aβ1-42. According
to [74], here we show that ROS, produced by the mitochondrial RC,
provide a redox signal which reversibly modiﬁes the thiol redox state
of mitochondrial ANT-1. Indeed, the reversible thiol redox modiﬁcation
of enzyme activity by ROS may be an important and unexplored mode
of mitochondrial redox signaling. Some mitochondrial proteins have
shown ROS-dependent thiol oxidation: peroxiredoxin III (PrxIII) [75],
NADP+-dependent isocitrate dehydrogenase [76], and Complex I
[77,78].
In order to investigate the role of ANT–SH groups in regulating
ANT-1 activity in the presence of pathological NH2htau and Aβ1-42
and under conditions in which they are the target of ROS, strategic ex-
periments were designed to determine whether speciﬁc protection
by mersalyl could prevent the impairment of ANT-1 caused by NH2-
htau and Aβ1-42 either added alone or together.
–SH group protection by mersalyl not only prevents the effect of
NH2htau, but not of Aβ1-42, on ANT-1 activity, but also abrogates
the toxic effect of NH2htau on ANT-1 when Aβ1-42 is already present.
These results, and the previous ones [18], converge toward a picture,
depicted in Scheme 1, in which NH2htau inhibits ANT-1 in a
MERS-prevented manner (panel A), while Aβ1-42 induces ROS
production and interacts with ANT-1 in a non-competitive manner.
Furthermore, Aβ1-42, added before the NH2htau fragment, strongly
reduces its ability to reach the ANT-1 active site and decreases its in-
hibitory action on mitochondrial function as a consequence of thiol
group/s oxidation and conformational changes in the carrier protein
(panel A′). In this regard it should be considered that, unlike Aβ, it
is unknown whether or not the NH2-tau fragment enters mitochon-
dria. Paradoxically, Aβ1-42 protects the cell from the inhibitory effect
of NH2htau on ANT-1 (see results reported in Table 2 together with
the experiment reported in Fig. 5).
In this regard, we observed that also ADP, added to cultured CGCs,
reduced the tau effectiveness in inhibiting ANT-1, like Aβ1-42 does
(manuscript in preparation). It might be possible that binding of ADP to
the carrier could grant protection against thiol oxidation by i) promoting
alterations of the ADP/ATP carrier conformation that change the position
of its thiol groups [79–81], rendering them not accessible to oxidation
by ROS or ii) changing mitochondria from the orthodox to condensed
conﬁguration, an alteration that may protect thiol groups of membrane
proteins against oxidation. This aspect is in agreement with the observa-
tion that ROS, while readily reacting with and damaging vital cellular
structures, among them lipids, DNA, and proteins [81], can also regulate
protein function thorough modiﬁcation of speciﬁc thiol(s). Over recent
years, an increasing number of proteins have been identiﬁed that are
Scheme 1. The molecular mechanism underlying the pathological Aβ-NH2htau interplay
on ANT-1 in AD involves thiol group/s present at the active site and the Aβ1-42-induced
ROS increase which can oxidize these –SH residues. A: NH2htau fragment affects ANT-1
under conditions in which no interplay with Aβ occurs. A′: NH2htau fragment affects
ANT-1 under conditions in which Aβ induced-ROS production oxidizes ANT-1 thiol/s
thus modulating NH2htau toxicity. See Discussion for details.
858 A. Bobba et al. / Biochimica et Biophysica Acta 1827 (2013) 848–860not damaged by oxidative stress conditions but use ROS-mediated thiol
modiﬁcations to speciﬁcally regulate their function [81].
Moreover, although the tau and Aβ pathologies are traditionally
considered as harbingers of neuronal damage in AD, we cannot abso-
lutely exclude an alternative, opposite interpretation that these
neurological lesions might be generated as a compensatory response
by neurons to attenuate this stress, thus representing an important
survival response [82–86]. It has been hypothesized that the Aβ
peptide, in an initial stage, may act as a ROS scavenger, with ROS pro-
duction being only observed in a later stage, possibly generated by
aggregated Aβ [71,86]. As a consequence, the pro- vs anti-oxidant
properties of Aβ and the timing of the aggregation vs the ROS produc-
tion are still greatly debated. Anyway during the preparation of this
manuscript, Müller's group has shown that mitochondrion-derived
ROS result in enhanced amyloidogenic amyloid precursor protein
processing, and that Aβ itself leads to mitochondrial dysfunction
and increased ROS levels, proposing that starting from mitochondrial
dysfunction a vicious cycle is triggered that contributes to the patho-
genesis of sporadic AD [87].5. Conclusions
The picture emerging from this and previous papers is that the
molecular mechanism underlying the pathological Aβ-NH2htau inter-
play on ANT-1 in AD neurons involves i) thiol groups present at the
active site [53] and ii) the ROS increase which can oxidize these –SH
residues, according to [37].Aside from that, an important point which requires further consid-
eration here is whether and how NH2htau and Aβ1-42 functional
interaction could occur in vivo; in this regard the time dependence
of the peptide formation is crucial. Literature data report that the
neuroﬁbrillary tangles appear long after the formation of Aβ plaques,
but the neuropathological connection between these two lesions is
still not clear [88]. An initial step in the pathogenesis may be the
intracellular effect of soluble Aβ on soluble not phosphorylated tau,
thus promoting tau phosphorylation and aggregation into PHF-like
ﬁlaments as well as Aβ nucleation [89–92]. But, interestingly,
evidence has been provided that tau is essential for Aβ-induced
neurotoxicity [83,93,94], reducing endogenous tau ameliorates amy-
loid beta-induced deﬁcits in AD mice [94] and Tau-knockout mice
exposed to Aβ peptide do not die [95]. Furthermore, it has also been
indicated that upon neuron death, monomeric tau becomes an extra-
cellular protein that could be toxic for the surrounding neurons [96].
Thus, if Aβ is already present when the tau fragment is still lacking, it
decreases the NH2htau effectiveness on ANT-1 function in a ROS-
dependent way, as our data suggest, assuming that Aβ dependent
ROS increase acts as modulator/blocker of tau fragment toxicity.
In this context, although, the relative contribution of tau and Aβ
remained unclear – as did possible synergistic effects – the patholog-
ical convergence between tau and Aβ on AD mitochondria may help
to explain why the diseased Aβ- or tau-modifying strategies have
not given promising results individually and suggest potential, new
pathway(s) and target(s) for a more efﬁcient combined therapeutic
intervention of early dysfunction in AD. In addition, the crucial role
of ANT-1 impairment in AD onset/progression opens a window for
new therapeutic strategies aimed to preserve/ameliorate mitochon-
drial function and represents an exciting challenge for biochemists.
Therefore, besides the treatment and/or removal of both pathological
Aβ and tau as well blocking the sites where Aβ initially binds to tau
fragment, strategies to protect cells at the mitochondrial level by sta-
bilizing or restoring mitochondrial function or by interfering with the
energy metabolism appear to be promising in treating or preventing
AD.
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